X - Pharma SA
X - Pharma reported total assets of 150,150 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 May 2026).
The score of X - Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +28 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
X - Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 May 2026
- Year ended 31 Dec 2024filed on 16 May 2025
- Year ended 31 Dec 2023filed on 22 May 2024
- Year ended 31 Dec 2022filed on 24 May 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
X - Pharma's financial analysis
- Solvency98.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of X - Pharma
X - Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.256.092
- VAT number
- BE0449256092
- Peppol
- Registered · 0208:0449256092 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Jan 1993
- Registered office
- 4800 Verviers
- Latest accounts
- 2025 · filed on 06 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
X - Pharma (SA) has been based in Verviers since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,962 € and equity of 148,387 €; its revenue is not published. Its solvency stands at 98.8%, above the median of its sector (41.5%).
Companies similar to X - Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Bousval Retail sale of pharmaceutical products Genappe · balance sheet 139,616 €
- Un Coquelicot Orange Retail sale of pharmaceutical products Courcelles · balance sheet 150,628 €
- Clement Pharma Services Retail sale of pharmaceutical products Meise · balance sheet 151,301 €
- Genaphar Retail sale of pharmaceutical products Brussels · balance sheet 147,330 €
- Louka Services Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 146,913 €
- Pharmattou Retail sale of pharmaceutical products Asse · balance sheet 146,566 €
- Jetpharma Retail sale of pharmaceutical products Jette · balance sheet 146,419 €
- By Nature Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 154,196 €
Frequently asked questions about X - Pharma
What is the revenue of X - Pharma?
X - Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of X - Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0449256092 for X - Pharma, if the company is VAT-registered. Its company number (CBE) is 0449.256.092.
Where is the registered office of X - Pharma?
According to the CBE register, the registered office of X - Pharma is in 4800 Verviers.
What is the equity of X - Pharma?
At the close of the 2025 financial year, the equity of X - Pharma amounts to 148,387 €, a solvency of 98.8% of total assets.
Who manages X - Pharma?
The register lists 5 active mandates at X - Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of X - Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →